Origami is capable of turning a simple sheet of paper into a pretty paper crane, but the principles behind the paper-folding art can also be applied to making a microfluidic device for a blood test, or for storing a satellite's solar panel in a rocket’s cargo bay.
Research and Markets has announced the addition of Jain PharmaBiotech's new report "Biochips and Microarrays - Technologies, Markets and Companies" to their offering.
The team from EPFL participating in the 2014 iGEM completion has been awarded a gold medal for their innovative Biopad design.
Fluidigm Corporation announced a new workflow that enables high throughput single-cell mRNA sequencing. This workflow, which was presented today at the Society for Neuroscience Conference, outlines significant advances in integrated fluidic circuit (IFC) design and chemistry to massively increase throughput and ease-of-use while simultaneously decreasing the cost of single-cell preparation. A full commercial version is expected to be available in the first half of 2015.
Epigem, a high-tech British micro engineering company, has made a major contribution to the EU-funded CoMMiTMenT (Combined Molecular Microscopy for Therapy and Personalised Medication in Rare Anaemia Treatments) project, a significant steptowards the creation of an ‘artificial spleen’.
Researchers at the Universitat Jaume I (UJI) have developed and patented a nanofluid improving thermal conductivity at temperatures up to 400°C without assuming an increase in costs or a remodeling of the infrastructure.
Scientists have been laboring to detect cancer and a host of other diseases in people using promising new biomarkers called "exosomes." Indeed, Popular Science magazine named exosome-based cancer diagnostics one of the 20 breakthroughs that will shape the world this year. Exosomes could lead to less invasive, earlier detection of cancer, and sharply boost patients' odds of survival.
A University of Texas at Arlington team exploring how neuron growth can be controlled in the lab and, possibly, in the human body has published a new paper in Nature Scientific Reports on how fluid flow could play a significant role.
A team of bioengineers, molecular biologists, and clinicians used a novel rare cell-sorter to isolate breast cancer cells from the blood of patients, with the aim of identifying the most effective drugs to treat each individual tumor. Circulating tumor cells (CTCs) were isolated and grown in the laboratory for extensive genetic analysis, which enabled the identification and testing of the most effective cancer-killing drugs for those tumors.
Last night the start-up Lunaphore, which is developing a rapid and precise system for cancer detection, won the PERL Prize (Entrepreneurial Prize for the Lausanne region). Awarding 50,000 Swiss francs to the winner, the prize is intended for innovative start-ups in the region. Another start-up from campus, G-Therapeutics, won the "coup de coeur du jury," receiveing 10,000 Swiss francs.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.